Cetirizini dihydrochloridum, Pseudoephedrini hydrochloridum

Medicinal product name Cirrus 5 mg/120 mg prolonged release tablets
Pharmaceutical form Prolonged-release tablet
Strength 5 mg/120 mg 
Information from the MAH on shortages Not available
predicted availability date: Jul 31, 2023
Legal status Rx Prescription (Pr.III)
Package leafletMS Word document 03-06-2021
Summary of product characteristicsMS Word document 03-06-2021
ATC code R01BA52 Nasal preparations

Medicinal products (2)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Not available (according to the information provided by wholesalers)
predicted availability date: Jul 31, 2023
currently no information on availability from any wholesaler N14
(5 mg/120 mg)
PVC/Al blister 7.09  04-0345-01 Labelling text Labelling text Dec 10, 2020
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N28
(5 mg/120 mg)
PVC/Al blister    04-0345-02 Labelling text Labelling text Dec 10, 2020

Registration information

Marketing authorisation No. 04-0345
Date of authorisation Jul 5, 2004
Marketing authorisation holder, country UCB Pharma Oy Finland, Finland